argus

PIRAMAL PHARMA LIMITED

NSE: PPLPHARMAINE0DK501011₹28,444 Cr

Timeline

Time (IST)TypeMEventSrc
11 Dec, 08:01 pm—…Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - FDA Inspectionbse
08 Dec, 06:21 pm—…Piramal Pharma Limited has informed the Exchange regarding Appointment of Mr Amit Soni as Non- Executive Independent Director of the company w.e.f. February 09, 2026.nse
08 Dec, 06:12 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
19 Nov, 04:53 pm—…Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
07 Nov, 03:17 pm—…Piramal Pharma Limited has informed the Exchange about Transcriptnse
07 Nov, 03:13 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
06 Nov, 12:30 pm—…Piramal Pharma Limited has informed the Exchange about Link of Recordingnse
06 Nov, 12:26 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
05 Nov, 09:05 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
05 Nov, 09:05 pm—…Piramal Pharma Limited has informed the Exchange about Investor Presentationnse
05 Nov, 09:03 pm—…Piramal Pharma Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Piramal Pharma Limited Announces Results for Q2 and H1 FY26".nse
05 Nov, 09:02 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
05 Nov, 09:00 pm—…Piramal Pharma Ltd - 543635 - Results - Financial Results For Quarter Ended September 30, 2025bse
05 Nov, 08:55 pm—…Piramal Pharma Ltd - 543635 - Board Meeting Outcome for Outcome Of Board Meeting Dated November 5, 2025bse
05 Nov, 08:55 pm—…Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
03 Nov, 05:29 pm—…Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
24 Oct, 12:08 pm—…Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Half Year Ended 30Th September, 2025.bse
16 Oct, 08:44 pm—…Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Withdrawal of Credit Rating.nse
16 Oct, 08:41 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
30 Sept, 06:38 pm—…Piramal Pharma Limited has informed the Exchange regarding 'intimation on change in the generic email id of Company's registrar & share transfer agent'.nse
30 Sept, 06:24 pm—…Piramal Pharma Ltd - 543635 - General - Updatebse
09 Sept, 06:56 pm—…Piramal Pharma Limited has informed the Exchange regarding 'Amendment to the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information'.nse
09 Sept, 06:52 pm—…Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015bse
02 Sept, 03:46 pm—…Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse